
Xarocad 15mg Tablet
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Rivaroxaban (15mg)
Overview Xarocad 15mg Tablet
Apixaban 15mg tablets function as an anticoagulant, effectively preventing and treating blood clots. This medication lowers the risk of stroke and heart attack by inhibiting clot formation in the legs, lungs, brain, and heart's veins. Frequently prescribed for patients with atrial fibrillation (irregular heartbeat), it also mitigates clot risk post-knee or hip replacement surgery. It can be administered with or without food, consistently at the same time daily for optimal efficacy. Long-term use, potentially lifelong, may be necessary; discontinuing or altering dosage without physician consultation significantly increases the risk of stroke, heart attack, or thrombosis. Lifestyle modifications – avoiding smoking, adopting a healthy diet, regular exercise, and weight management (if needed) – further reduce clot risk. Increased bleeding (e.g., nosebleeds, bruising) is a common side effect; report any symptom to your doctor immediately. Contraindicated in individuals with severe liver or kidney disease, active bleeding, or concurrent use of other anticoagulants. Breastfeeding is not advised during treatment. Unlike some anticoagulants, routine PT-INR monitoring isn't typically required.
Primary Ingredients of Xarocad 15mg Tablet
The provided text is "undefined," which lacks meaning and cannot be rephrased.
Uses of Xarocad 15mg Tablet
Managing and averting blood clot formation
Major Benefits of Xarocad 15mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Xarocad 15mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Xarocad 15mg Tablet:
- Bleeding
How to use Xarocad 15mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Xarocad 15mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Xarocad 15mg Tablet works:
Xarelto 15mg tablets represent a new class of oral blood thinners. Their mechanism involves inhibiting factor Xa, a crucial clotting protein, thereby reducing the risk of blood clot development.
SAFETY ADVICE
AlcoholCAUTION
Use of Xarocad 15mg Tablets with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Xarocad 15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Xarocad 15mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving may be impaired by Xarocad 15mg Tablet, which can induce dizziness or fainting. These side effects could compromise your ability to operate a vehicle safely.
KidneyCAUTION
Individuals with impaired kidney function should use Xarocad 15mg Tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised. Xarocad 15mg Tablets are contraindicated for patients exhibiting severe kidney disease.
LiverUNSAFE
The use of Xarocad 15mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Seek medical counsel.
What if you forget to take Xarocad 15mg Tablet :
Should you forget a Xarocad 15mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosage regimen. Avoid taking a double dose.
Facts to Know About Xarocad 15mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Morpholine- and thiophene-based derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | Xa Inhibitors for Oral Administration |
